COMMUNIQUÉS West-GlobeNewswire

-
U.S. Patent Office Awards Diffusion Exclusive Rights for Use of TSC in Conjunction with Only FDA-Approved Stroke Therapeutic
17/12/2018 - 15:55 -
Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025
17/12/2018 - 15:30 -
PRODUCTION OF PHA BIOPLASTICS IN SPAIN: STRATEGIC AGREEMENT BETWEEN BIO-ON AND ACOR
17/12/2018 - 15:29 -
Merit Medical Acquires Assets of Vascular Insights, LLC
17/12/2018 - 15:25 -
FDA Approves Smart Programmer for the InterStim System
17/12/2018 - 15:01 -
How California Can Overcome Its Cannabis Challenges -- CFN Media
17/12/2018 - 15:00 -
Protech Home Medical Acquires Riverside Medical and Central Oxygen
17/12/2018 - 15:00 -
Farmako: Biggest non-Canadian investment in Europe to date With Seven-digit Investment by Heartbeat Labs
17/12/2018 - 15:00 -
Pluristem Therapeutics Recaps Key Opinion Leader Meeting on Peripheral Artery Disease (PAD)
17/12/2018 - 14:40 -
Kiniksa Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare Conference
17/12/2018 - 14:36 -
Teladoc Health Chief Operating Officer and Chief Financial Officer Resigns
17/12/2018 - 14:35 -
Novo Nordisk A/S - Share repurchase programme
17/12/2018 - 14:33 -
Terranueva Corporation to Begin Trading on the Canadian Securities Exchange
17/12/2018 - 14:30 -
Début de la négociation des titres de Corporation Terranueva à la Bourse des valeurs canadiennes
17/12/2018 - 14:30 -
Hemispherx Biopharma Inc. Announces Updated Information about ME/CFS Expanded Access Program in the United States
17/12/2018 - 14:30 -
Acer Therapeutics Appoints Salma Jutt as Chief Commercial Officer
17/12/2018 - 14:30 -
Uptick Newswire Hosts Progressive Care Inc’s CEO to Discuss an Exciting New Acquisition Prospect and Company Growth
17/12/2018 - 14:30 -
ExCellThera receives FDA orphan drug designation for ECT-001 for the prevention of graft-versus-host disease
17/12/2018 - 14:05 -
Closing of the Transaction of $10,930,000 with Terranueva Pharma Corporation and Concurrent Private Placement of $2,310,000
17/12/2018 - 14:00
Pages